The purpose of this study was to explore the mechanism of C-MYC in the regulation of ferroptosis and immune evasion of ovarian cancer patients through in vivo, in vitro and clinical studies, and thus provide new therapeutic targets to alleviate the chemotherapy resistance of ovarian cancer cases. This evidence concerns the gene MYC and ovarian cancer.